Clinical trials: Molecular Classification of HNSCC

Molecular Classification of HNSCC

HNSCC Immuno-genomics Project

• Completed
• Age: 18 to 100 years
• Observational study

For locally advanced and recurrent / metastatic head \& neck squamous cell carcinoma (HNSCC), the is an unmet need for the development of efficient treatment combinations, particularly with immune checkpoint inhibitors.

Trial name

NCT06725342

Testing

Combined DNA/RNA sequencing on clinical FFPE material (technically challenging; innovative); immuno-genomics test.

Volunteers

401 people

Sponsor

Hellenic Cooperative Oncology Group